The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 157.6 Billion by 2028, exhibiting a CAGR of 3.23% during 2022-2028.
Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.
Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.
Anti-infectives Market Trends:
The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration and distribution channel.Breakup by Type:
- Antibacterial
- Antifungal
- Antiviral
Breakup by Route of Administration:
- Topical
- Oral
- Intravenous (IV)
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Speciality Pharmacies
- Online Stores
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.Key Questions Answered in This Report:
- How has the global anti-infectives market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global anti-infectives market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global anti-infectives market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anti-infectives Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Antibacterial
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Antifungal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Antiviral
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Topical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Intravenous (IV)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Speciality Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Online Stores
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Cipla Health Ltd. (Cipla Limited)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 F. Hoffmann-La Roche AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 GlaxoSmithKline plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Glenmark Pharmaceuticals Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Johnson & Johnson
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Lupin Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Sandoz AG (Novartis AG)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Sun Pharmaceutical Industries Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
List of Figures
Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
Figure 2: Global: Anti-infectives Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2022
Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2022
Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Anti-infectives Industry: SWOT Analysis
Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Anti-infectives Market: Competitive Structure
Table 7: Global: Anti-infectives Market: Key Players
Companies Mentioned
- Abbott Laboratories
- Cipla Health Ltd. (Cipla Limited)
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Johnson & Johnson
- Lupin Limited
- Sandoz AG (Novartis AG)
- Sun Pharmaceutical Industries Limited.
Methodology
LOADING...
